EvogeneEVGN
13F holders, Q3 2024 (September 30)14holders
$3.07avg. 13F price*
At the end of Q3 2024, 14 institutions reported holding Evogene Ltd. (EVGN) in their 13F filings. The largest holders were Silverarc Capital Management, LLC ($945K), Armistice Capital, LLC ($598K) and Morgan Stanley ($39K).
- Company
- Evogene Ltd.
- CUSIP
- M4119S187
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $629K |
| Exits | 0 | $0 |
Ownership 14 holders
| Silverarc Capital Management, LLC | 0.21% | No change | 307,974 | $945K |
| Armistice Capital, LLC | 0.02% | New | 194,692 | $598K |
| Morgan Stanley | 0.00% | Reduce -42.3% | 12,605 | $39K |
| BNP Paribas Financial Markets | 0.00% | Add +21.5% | 12,200 | $37K |
| Renaissance Investment Group LLC | 0.01% | New | 10,000 | $31K |
| UBS Group AG | 0.00% | Add +30.3% | 8,601 | $26K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 3,803 | $12K |
| JPMorgan Chase & Co. | 0.00% | Reduce -57.3% | 639 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 540 | $2K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 500 | $2K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 500 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 290 | $890 |
| Bank of America Corp. | 0.00% | Reduce -78.4% | 138 | $423 |
| Royal Bank of Canada | 0.00% | Reduce -8.9% | 42 | $0 |
"% of holder's portfolio" is EVGN's weight in each manager's 13F, not the share of Evogene Ltd. the manager owns.